Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 14/20 | 0.62 |
| ▸ | PARP2 | Q9UGN5 | 2/20 | 0.48 |
| ▸ | PROKR1 | Q8TCW9 | 2/20 | 0.44 |
| ▸ | DRD3 | P35462 | 1/20 | 0.44 |
| ▸ | ACHE | P22303 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5621265 | 0.94 | PARP1 (0.70) | PARP1PARP2 | |
| SCHEMBL5620344 | 0.89 | PARP1 (0.77) | PARP1PARP2 | |
| SCHEMBL5621116 | 0.86 | PARP1 (0.67) | PARP1PARP2DRD3 | |
| SCHEMBL7043749 | 0.86 | ACHE (0.45) | PARP1PROKR1DRD3ACHE | |
| SCHEMBL5621147 | 0.85 | PARP1 (0.64) | PARP1PARP2DRD3 | |
| SCHEMBL5621929 | 0.85 | PARP1 (0.64) | PARP1PARP2DRD3 | |
| SCHEMBL7700467 | 0.85 | PARP1 (0.67) | PARP1PARP2DRD3 | |
| SCHEMBL5621780 | 0.84 | PARP1 (0.66) | PARP1PARP2DRD3 | |
| SCHEMBL5620538 | 0.83 | PARP1 (0.56) | PARP1PARP2 | |
| SCHEMBL5621198 | 0.82 | PARP1 (0.61) | PARP1PARP2DRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE39608-E1 | Substituted benzimidazoles and their use as PARP inhibitors | ABBOTT GMBH & CO. KG (DE) | 2007-05-01 | — | — | US | disclosed |
| US-6448271-B1 | SUCH AS 2-(PIPERIDIN-4-YL)BENZIMIDAZOLE-4-CARBOXAMIDE; INHIBITORS OF ENZYME POLY(ADP-RIBOSE)POLYMERASE; IMPROVED WATER SOLUBILITY | BASF AKTIENGESELLSCHAFT (DE) | 2002-09-10 | — | — | US | disclosed |